The DOI matches its Crossref record.
Acute Release of Plasminogen Activator Inhibitor-1 in ST-Segment Elevation Myocardial Infarction Predicts Mortality
Open accessAbstract
Background— A few studies have suggested that von Willebrand factor (vWF) or plasminogen activator inhibitor-1 (PAI-1) can be associated with outcomes of acute coronary syndromes. The present study was designed to assess the acute release of these markers in ST-segment elevation myocardial infarction (STEMI) and their relations to death. Methods and Results— In 153 consecutive patients with STEMI, vWF and PAI-1 antigens were measured on admission (H0) and 24 hours later (H24). At 30 days, the death rate was 7.2%. Heart failure (Killip stage ≥3) on admission was present in 13.7% of patients. The acute release of PAI-1 (H24−H0, in ng/mL) and of vWF (H24−H0, in %) was dramatically higher in patients who died than in those who survived (46.9±26.3 versus −0.6±2.8 ng/mL, P =0.0001 and 65.8±20.0% versus 10.0±5.1%, P =0.004 for PAI-1 and vWF, respectively) and in patients developing heart failure compared with those without (24.8±10.1 versus −1.1±3.3 ng/mL, P =0.004 and 47.3±11.0% versus 8.1±5.6%, P =0.005 for PAI-1 and vWF, respectively). The release of PAI-1 correlated weakly with the left ventricular ejection fraction ( R =−0.195, P =0.01) and the peak of troponin ( R =0.149, P =0.045). Postangioplasty TIMI-3 flow and the acute release of PAI-1 were the only 2 independent predictors of death at 30 days. Conclusions— The acute release of vWF and PAI-1 over the first 24 hours of STEMI is associated with death and heart failure. The acute rise of PAI-1 is also a strong independent predictor of death at 30 days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Oddo, M., Schaller, M.-D., Feihl, F., Ribordy, V., & Liaudet, L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000221922.08878.49 · Cited by 593
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
Meshkani, R., & Adeli, K. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.018 · Cited by 458
Cesari, M., Pahor, M., & Incalzi, R. A. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00171.x · Cited by 448
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G., & Mehta, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000133444.17867.56 · Cited by 422
Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes
Spiel, A. O., Gilbert, J. C., & Jilma, B. (2008) · Circulation · doi:10.1161/circulationaha.107.722827 · Cited by 402
Metadata
- Authors
- Collet, J. P., Montalescot, G., Vicaut, E., Ankri, A., Walylo, F., Lesty, C., Choussat, R., Beygui, F., Borentain, M., Vignolles, N., & Thomas, D.
- Venue
- Circulation
- Published
- 2003-07-29
- Volume
- 108
- Issue
- 4
- Pages
- 391-394
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2128142528
- Cited by
- 158
- References
- 0
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute Release of Plasminogen Activator Inhibitor-1 in ST-Segment Elevation Myocardial Infarction Predicts Mortality. https://app.cochat.ai/papers/10.1161/01.cir.0000083471.33820.3c
- The paper
- Collet, J. P., Montalescot, G., Vicaut, E., Ankri, A., Walylo, F., Lesty, C., Choussat, R., Beygui, F., Borentain, M., Vignolles, N., & Thomas, D. (2003). Acute Release of Plasminogen Activator Inhibitor-1 in ST-Segment Elevation Myocardial Infarction Predicts Mortality. Circulation. https://doi.org/10.1161/01.cir.0000083471.33820.3c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.